UBS Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-50,739
| Closed | -$1.69M | – | 10023 |
|
2022
Q4 | $1.69M | Buy |
50,739
+20,672
| +69% | +$687K | ﹤0.01% | 2707 |
|
2022
Q3 | $948K | Buy |
30,067
+23,059
| +329% | +$727K | ﹤0.01% | 2888 |
|
2022
Q2 | $213K | Sell |
7,008
-216,759
| -97% | -$6.59M | ﹤0.01% | 3889 |
|
2022
Q1 | $5.81M | Sell |
223,767
-3,481
| -2% | -$90.4K | ﹤0.01% | 1814 |
|
2021
Q4 | $4.64M | Buy |
227,248
+220,942
| +3,504% | +$4.51M | ﹤0.01% | 2163 |
|
2021
Q3 | $122K | Sell |
6,306
-1,708
| -21% | -$33K | ﹤0.01% | 4623 |
|
2021
Q2 | $178K | Sell |
8,014
-27,038
| -77% | -$601K | ﹤0.01% | 4423 |
|
2021
Q1 | $920K | Buy |
35,052
+1,376
| +4% | +$36.1K | ﹤0.01% | 3447 |
|
2020
Q4 | $630K | Buy |
33,676
+4,770
| +17% | +$89.2K | ﹤0.01% | 3511 |
|
2020
Q3 | $491K | Sell |
28,906
-3,686
| -11% | -$62.6K | ﹤0.01% | 3448 |
|
2020
Q2 | $759K | Sell |
32,592
-985
| -3% | -$22.9K | ﹤0.01% | 3040 |
|
2020
Q1 | $282K | Sell |
33,577
-23,389
| -41% | -$196K | ﹤0.01% | 3644 |
|
2019
Q4 | $556K | Buy |
56,966
+18,448
| +48% | +$180K | ﹤0.01% | 3816 |
|
2019
Q3 | $365K | Buy |
38,518
+21,680
| +129% | +$205K | ﹤0.01% | 3944 |
|
2019
Q2 | $200K | Buy |
16,838
+9,253
| +122% | +$110K | ﹤0.01% | 4106 |
|
2019
Q1 | $134K | Sell |
7,585
-16,206
| -68% | -$286K | ﹤0.01% | 4101 |
|
2018
Q4 | $413K | Buy |
23,791
+4,547
| +24% | +$78.9K | ﹤0.01% | 3631 |
|
2018
Q3 | $287K | Buy |
19,244
+5,837
| +44% | +$87.1K | ﹤0.01% | 3992 |
|
2018
Q2 | $213K | Buy |
13,407
+4,182
| +45% | +$66.4K | ﹤0.01% | 4052 |
|
2018
Q1 | $131K | Sell |
9,225
-2,907
| -24% | -$41.3K | ﹤0.01% | 4239 |
|
2017
Q4 | $170K | Sell |
12,132
-4,493
| -27% | -$63K | ﹤0.01% | 4128 |
|
2017
Q3 | $238K | Sell |
16,625
-477,119
| -97% | -$6.83M | ﹤0.01% | 3896 |
|
2017
Q2 | $7.78M | Buy |
493,744
+476,845
| +2,822% | +$7.51M | ﹤0.01% | 1374 |
|
2017
Q1 | $233K | Sell |
16,899
-2,634
| -13% | -$36.3K | ﹤0.01% | 3743 |
|
2016
Q4 | $345K | Buy |
19,533
+6,512
| +50% | +$115K | ﹤0.01% | 3568 |
|
2016
Q3 | $251K | Sell |
13,021
-6,246
| -32% | -$120K | ﹤0.01% | 3584 |
|
2016
Q2 | $375K | Buy |
19,267
+153
| +0.8% | +$2.98K | ﹤0.01% | 3354 |
|
2016
Q1 | $394K | Buy |
19,114
+6,077
| +47% | +$125K | ﹤0.01% | 3285 |
|
2015
Q4 | $268K | Sell |
13,037
-3,927
| -23% | -$80.7K | ﹤0.01% | 3585 |
|
2015
Q3 | $290K | Sell |
16,964
-4,676
| -22% | -$79.9K | ﹤0.01% | 3465 |
|
2015
Q2 | $404K | Sell |
21,640
-76,275
| -78% | -$1.42M | ﹤0.01% | 3402 |
|
2015
Q1 | $1.87M | Buy |
97,915
+14,806
| +18% | +$282K | ﹤0.01% | 2343 |
|
2014
Q4 | $1.37M | Buy |
+83,109
| New | +$1.37M | ﹤0.01% | 2534 |
|